Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
03/2001
03/15/2001WO2000075113A8 Novel heterocyclic carboxamide derivatives
03/15/2001WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
03/15/2001DE4092096C1 1,4-Disubstituierte 2,6-Difluorbenzolverbindungen und flüssigkristallines Medium 1,4-Disubstituted 2,6-Difluorbenzolverbindungen and liquid crystalline medium
03/15/2001DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties
03/15/2001DE19942474A1 Pyrazolo[4,3-d]pyrimidine Pyrazolo [4,3-d] pyrimidines
03/14/2001EP1083172A1 N-substituted derivatives of 5-oxyiminobarbituric acid
03/14/2001EP1082311A1 Quinazolines for treating brain tumor
03/14/2001EP1082310A1 Methods of identifying and using hla binding compounds as hla-agonists and antagonists
03/14/2001EP1082308A1 Heterocyclically substituted amides used as calpain inhibitors
03/14/2001EP1082303A1 Heterocyclic derivatives which inhibit factor xa
03/14/2001EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors
03/14/2001EP1082155A2 Dry powder dispersing apparatus and methods for their use
03/14/2001EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/13/2001US6201121 Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives
03/13/2001US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction
03/13/2001US6200981 For treating inflammatory diseases such as asthma, inflammatory bowel disease, psoriasis, rheumatoid arthritis, myocardial ischaemia, cystic fibrosis, arthereosclerosis, restenosis, peridontal disease, septic shock, osteoarthritis
03/13/2001US6200977 Pyrimidine derivatives
03/13/2001US6200976 Antithrombotic quinoxazolines
03/13/2001US6200971 For treating atherosclerosis
03/13/2001US6200654 1,4-disubstituted 2,6-difluorobenzene compounds, and a liquid-crystalline medium
03/08/2001WO2001016131A2 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
03/08/2001WO2001016121A1 Heterocyclic compounds and methods of use thereof
03/08/2001WO2001016114A2 Heterocyclic compounds and methods for modulating cxcr3 function
03/08/2001WO2001016108A2 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/08/2001WO2001016107A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors
03/08/2001WO2000066565A8 Pesticidal pyrimidine-derivatives
03/08/2001WO1999063930A8 Novel angiotensin receptor modulators and their uses
03/08/2001DE19941656A1 New fluorothiophene, furan, isoxazole, thiazole, cyclopentane, cyclopentene and alkylfluorothiophenecarboxylic acid compounds are useful in liquid crystals mixtures and synthesis of liquid crystals, agrochemicals and pharmaceuticals
03/08/2001DE19941655A1 New cyclohexane derivatives for use in liquid crystal mixtures especially for use in ferroelectric switching and/or display devices with active matrix elements
03/08/2001DE19941654A1 New fluorothiophene, furan, isoxazole, thiazole, cyclopentane, cyclopentene and alkylfluorothiophenecarboxylic acid compounds are useful in liquid crystals mixtures and synthesis of liquid crystals, agrochemicals and pharmaceuticals
03/08/2001CA2384435A1 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/08/2001CA2383307A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors
03/07/2001EP1081140A2 Novel Pyrimidine-2,4,6-trione compounds
03/07/2001EP1080726A1 Agents for relieving side effects
03/07/2001EP1080092A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
03/07/2001EP1080086A1 Dihydropyrimidines
03/07/2001EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
03/07/2001EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors
03/07/2001EP1080079A1 Thermally stable trimetrexates and processes for producing the same
03/07/2001EP1080077A1 Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes
03/07/2001EP1080068A1 Modulators of protein tyrosine phosphatases
03/07/2001EP1079917A1 Complexes of ultraviolet absorbers and quaternary ammonium compounds which are substantially free from unwanted salts
03/07/2001EP1079821A1 Protease inhibitors
03/07/2001EP0836594B1 Benzylhydroxylamines and intermediates used to prepare them
03/07/2001EP0736015B1 Antiviral 2,4-pyrimidindione derivatives and processes for the preparation thereof
03/07/2001CN1286254A Aromatic amino ether as analgesics
03/07/2001CN1062865C Process for production of amidinobenzofuran and amidinobenzothiophen derivs. and salt thereof
03/06/2001US6198011 Fluorinating chlorine containing organic compound comprising reacting in solvent reaction medium organic compound with alkali metal fluoride wherein solvent at least before reaction starts comprises perfluorocarbon
03/06/2001US6197958 Carboxylic acid derivatives, their preparation and use
03/06/2001US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
03/06/2001US6197785 Cardiovascular disorders
03/06/2001US6197782 Therapy for sexual disorders
03/06/2001US6197780 Administering an endothelin anatgonist
03/06/2001US6197779 HIV inhibiting pyrimidine derivative
03/06/2001US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
03/06/2001US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
03/06/2001US6197729 Combating pest which comprises applying to pest or its locus pesticidal cyclohexylaminopyrimidinne compound
03/06/2001CA2223081C Heterocyclic ring-fused pyrimidine derivatives
03/06/2001CA2183655C 4-polycyclic amino-substituted quinazoline derivatives
03/06/2001CA1341201C Bis-(hydroxymethyl) cyclobutyl purines and pyrimidines
03/01/2001WO2001014371A1 N-heterocyclic derivatives as nos inhibitors
03/01/2001WO2001014355A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments
03/01/2001WO2001014345A1 5-propynylpyrimidine derivatives as cytotoxic enzyme inhibitors
03/01/2001WO2001014344A2 Polycyclic pyrimidine-2,4(1h, 3h)-dione with functionalized alkyl radicals in 1- and/or 3-position, method for the production thereof and pharmaceutical preparations
03/01/2001WO2001014339A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/01/2001WO2001014338A1 NOVEL INTEGRIN αVβ3 INHIBITORS
03/01/2001WO2001014337A1 αvβ3 INTEGRIN INHIBITORS
03/01/2001WO2001014320A1 Compounds that inhibit tryptase activity
03/01/2001WO2001014310A1 PLEUROMUTILIN β-KETOESTERS
03/01/2001WO2001000617A3 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same
03/01/2001DE19939981A1 Neue Inhibitoren des Integrins alphavß3 New inhibitors of integrin alphavß3
03/01/2001DE19939980A1 Inhibitoren des Integrins alphavbeta¶3¶ Inhibitors of integrin alphavbeta¶3¶
03/01/2001DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity
03/01/2001CA2382850A1 Novel inhibitors of the integrin .alpha.v.beta.3
03/01/2001CA2382561A1 Inhibitors of integrin .alpha.v.beta.3
03/01/2001CA2382311A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments
03/01/2001CA2381096A1 Compounds that inhibit tryptase activity
03/01/2001CA2376275A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
02/2001
02/28/2001EP1077957A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
02/28/2001EP1077950A1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments
02/28/2001EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
02/28/2001EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
02/28/2001EP0792255B1 Liquid crystal compounds having perfluoroether terminal portions
02/28/2001EP0429611B1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins
02/28/2001CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease
02/28/2001CN1285349A Process for preparation of 4.6-dicloro-5-fluoropyrimidine
02/28/2001CN1062559C 4-aryl oximidoether quinazoline compound and its synthesis process and application
02/27/2001US6194447 Bis (benzimidazole) derivatives serving as potassium blocking agents
02/27/2001US6194420 Blood disorders; reduce platelet concentration
02/27/2001US6194418 Bactericides, pesticides
02/27/2001CA2101316C Gnrh analogs
02/27/2001CA1341187C Composition to induce and stimulate the growth of hair and/or slow down their shedding, based on a nonionic surfactant and a pyrimidine derivative
02/22/2001WO2001012615A2 Fungicidal heteroaryl hepta-2,6-dienoic acid derivatives
02/22/2001WO2001012611A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
02/22/2001WO2001012604A1 Fungicides
02/22/2001WO2000055126A3 N-cyanomethylamides as protease inhibitors
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/22/2001DE19948933A1 Verfahren zur Herstellung von 4-6-Dichlor-5-fluorpyrimidin Process for the preparation of 4-6-dichloro-5-fluoropyrimidine
02/22/2001DE19939516A1 New 1-carboxyalkyl-4-(hetero)aryl-piperazine derivatives, as microsomal triglyceride transfer protein inhibitors useful for reducing plasma atherogenic lipoprotein levels, e.g. in treatment of hyperlipidemia
02/22/2001CA2381551A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors